Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer

BACKGROUND: When ipsilateral multifocal primary breast cancer (IMBC) is detected, standard routine is to evaluate the largest tumor with immunohistochemistry (IHC). As all foci are not routinely characterized, many patients may not receive optimal adjuvant treatment. Here, we assess the clinical rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Janeva, Slavica, Krabbe, Ellen, Parris, Toshima Z., Nasic, Salmir, Sundquist, Marie, Karlsson, Per, Audisio, Riccardo A., Olofsson Bagge, Roger, Kovács, Anikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080895/
https://www.ncbi.nlm.nih.gov/pubmed/37024949
http://dx.doi.org/10.1186/s13058-023-01632-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080895/
https://www.ncbi.nlm.nih.gov/pubmed/37024949
http://dx.doi.org/10.1186/s13058-023-01632-5

Ejemplares similares